China Health Industries Holdings, Inc. (CHHE) Revenue (2017 - 2024)
China Health Industries Holdings (CHHE) has disclosed Revenue for 13 consecutive years, with $87.0 as the latest value for Q1 2024.
- For the quarter ending Q1 2024, Revenue fell 99.59% year-over-year to $87.0, compared with a TTM value of $95946.0 through Mar 2024, up 17.09%, and an annual FY2023 reading of $111579.0, up 41689.89% over the prior year.
- Revenue was $87.0 for Q1 2024 at China Health Industries Holdings, up from $46.0 in the prior quarter.
- Across five years, Revenue topped out at $3.1 million in Q4 2020 and bottomed at -$2.0 in Q2 2022.
- Average Revenue over 5 years is $654520.8, with a median of $34483.0 recorded in 2022.
- The sharpest move saw Revenue crashed 100.0% in 2022, then surged 2875750.0% in 2023.
- Year by year, Revenue stood at $3.1 million in 2020, then crashed by 100.0% to $2.0 in 2021, then skyrocketed by 1302200.0% to $26046.0 in 2022, then tumbled by 99.82% to $46.0 in 2023, then surged by 89.13% to $87.0 in 2024.
- Business Quant data shows Revenue for CHHE at $87.0 in Q1 2024, $46.0 in Q4 2023, and $38300.0 in Q3 2023.